Piermont Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,000	Closed	-$229K	–	133
2018 Q2	$229K	Sell	10,000 -1,820	-15%	-$41.7K	0.07%	224
2018 Q1	$336K	Sell	11,820 -1,850	-14%	-$52.6K	0.11%	213
2017 Q4	$289K	Sell	13,670 -760	-5%	-$16.1K	0.09%	218
2017 Q3	$262K	Buy	+14,430	New	+$262K	0.09%	227